Certara Announces Acquisition of Great Lakes Drug Development, Inc.
Acquisition will further increase the depth of Certara?s early drug development analysis, modeling and simulation expertise
Certara
™, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that it has acquired drug development consultancy firm, Great Lakes Drug Development, Inc. (“GLDD”), based in Brighton, MI. Both companies possess considerable expertise in pharmacokinetic (PK) and pharmacodynamic (PD) analysis, project management, and pharmacometric modeling and simulation. GLDD focuses on early development work, while Certara’s products and services span the entire drug development continuum. Financial details about the transaction have not been disclosed.
“This acquisition will enable us to leverage the significant synergies between Certara’s and GLDD’s business focus, experience, and culture, while expanding our customer base,” said Daniel Weiner, Ph.D., senior vice president and general manager at Certara.
The addition of GLDD builds on the capabilities Tripos®, Pharsight® and Simcyp™ bring to Certara.
GLDD’s Chief Executive Officer David Hermann, said, “This is an exciting stage in our company’s evolution. We look forward to joining Certara’s Pharsight Consulting Services to enhance their capabilities and provide our customers with access to additional services and expertise.”
The GLDD office in Brighton, MI will become the sixth in Certara’s worldwide consultancy operations including 75 Ph.D. staff in Sunnyvale, CA; Cary, NC; Montreal, Canada; Tokyo, Japan; and Sheffield, England.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
